Government

Part D formulary guideline changes proposed

The U.S. Pharmacopeial Convention suggests adding some specific vaccine types to guidelines on Medicare drug lists.

By David Glendinning — Posted Dec. 11, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The group that advises Medicare drug plans on what medications to cover is seeking advice from physicians and others on how to adjust those recommendations for 2007.

The U.S. Pharmacopeial Convention has proposed several additions, deletions and clarifications to its drug formulary guidelines and will accept public comments on the new list. The guidelines do not mention any medications by name but include drug therapeutic categories, pharmacological classes and "formulary key drug types."

Medicare drug plans are not required to follow the guidelines when crafting their approved drug lists, but those that cover at least two medications in each category or class, as well as at least one drug of each key type, will get less scrutiny from federal officials when it comes time to approve the formularies.

Most changes that USP has proposed involve additions to the formulary key drug types. Instead of just covering "vaccines," for instance, the group is now encouraging plans to cover specific ones, such as "vaccines to prevent meningococcal disease."

In other areas, the guidelines are less specific. Instead of listing oral and parenteral bisphosphonates as separate key types, for example, USP is proposing putting all bisphosphonates under a single type.

Physicians complained last year when the group released its formulary guidelines for the opening year of the Medicare drug benefit. At the time doctors said the categories and classes listed did not cover several therapies they deemed vital.

The USP has a new tool to help plans put together formularies. A separate drug list table gives examples by drug name for each category, class and type. This list was not required by Medicare officials, who are awaiting the final formulary guidelines by Feb. 5.

Back to top


External links

U.S. Pharmacopeial Convention, for draft Medicare drug formulary guidelines and public comment instructions (link)

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn